3 completed, 1 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow tocotrienol, delta: new trials by email Literature Review of tocotrienol, delta trials Research Report on tocotrienol, delta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) Vitamin E Delta Tocotrienol, Placebo - Neoplasm of Pancreas, IPMN, Pancreatic | Phase 2 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 4 | 2024-07-09 | 2025-11-13 |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects Vitamin E δ-Tocotrienol - Pancreatic Cancer | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 18 | 2011-10-01 | 2016-07-07 |
| Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects Vitamin E δ-Tocotrienol - Pancreatic Cancer | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 18 | 2011-09-01 | 2016-04-11 |
| Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia Vitamin E δ-Tocotrienol - Pancreatic Neoplasms | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 26 | 2009-09-01 | 2016-03-01 |
Pancreatic Neoplasms (4) · Pancreatic Intraductal Neoplasms (2)
H. Lee Moffitt Cancer Center and Research Institute (4)
United States (4)
Jason Klapman, M.D. (2) · Gregory Springett, M.D., Ph.D. (1) · Mokenge P Malafa, MD, FACS (1)
R01CA129227 (1), R01CA263575 (1)